NCT03263364Unknown不适用
Genomic Screening for Hereditary Erythrocytosis and Related Diseases
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 150
- 试验地点
- 2
- 主要终点
- Germline mutations that cause Hereditary Erythrocytosis/Idiopathic Erythrocytosis
研究概览
简要总结
Unexplained polycythemias are rare diseases, and therefore, the collection of data inherent to these diseases will not only improve their characterisation, but also allow stratification according to the risks and the course of the disease. The objective of this project is to constitute a database on the disease which will allow us to better understand it and in due course improve its management.
The GENRED project thus bears uniquely on the collection of information, which will be gathered throughout the usual management of patients for this type of disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The characteristics of the patients included in the database will be described in terms of numbers and percentages for qualitative variables and in terms of means and standard deviations or medians and interquartile intervals for quantitative variables.
排除标准
- •The first step will be to exclude acquired secondary (pulmonary, renal and cardiac) or acquired primary (polycythemia vera due to JAK2 mutations) causes. The family history and the determination of serum EPO levels are very useful in the decision regarding which molecular tests should be performed first.
- •patients without absolute erythrocytosis (i.e. without an increased red cell mass >125% of mean predicted value, or if the haematocrit is <60% in males or <56% in females.
- •erythrocytosis related to polycythemia vera according to the 2008 WHO (World Health Organization) criteria
- •Secondary erythrocytosis related to an obvious cause (renal lesions, chronic lung or heart diseases, endocrine lesions, miscellaneous tumours producing EPO, drugs such as androgens, hepatic lesions...)
- •Low venous blood p50: the determination of p50 (percentage at which Hb is half saturated with oxygen) is very helpful is establishing the presence of a haemoglobin variant with high oxygen affinity or a rare 2,3-diphosphoglycerate (2,3-DPG) deficiency. In such a situation, a specific HBB, HBA1 and HBA2 mutation will be screened for using Sanger sequencing (these genes are not included in NGS analysis because of redundancy of pseudogenes).
- •In order to rule out non-informative erythrocytosis cases, a form including mandatory further tests must be filled in for a selection step. The required tests are: complete blood counts
- •Blood electrolytes
- •Arterial and venous gazes
- •Serum erythropoietin dosage
- •Liver function tests
- •JAK2 mutations (both V617F and exon 12)
- •Bone marrow aspirate and/or biopsy and/or endogenous BFU-E culture
- •Abdominal ultrasound
- •Lung function tests
结局指标
主要结局
Germline mutations that cause Hereditary Erythrocytosis/Idiopathic Erythrocytosis
时间窗: at baseline
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Investigation of the Genetics of Hematologic DiseasesSevere Congenital NeutropeniaBone Marrow Failure SyndromesErythrocyte DisorderLeukocyte DisorderHemostasisBlood Coagulation DisorderDyskeratosis CongenitaDiamond-Blackfan AnemiaCongenital ThrombocytopeniaMyelodysplastic SyndromesMyeloproliferative DiseasesSickle Cell DiseaseFanconi AnemiaNCT02720679St. Jude Children's Research Hospital1,716
招募中
不适用
Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)Undiagnosed DiseasesCardiovascular DiseaseNCT02543996National Heart, Lung, and Blood Institute (NHLBI)10,000
招募中
不适用
Genome Medical Sequencing for Gene DiscoveryIntellectual DisabilitiesCongenital AnomalyRare DisordersNCT01087320National Human Genome Research Institute (NHGRI)2,000
撤回
不适用
Finding Genes for Rare DiseasesRare DiseasesNCT02724995University of Kentucky
招募中
不适用
Diagnostic Research in Patients With Rare Diseases -Solving the Unsolved Rare DiseasesRare DiseasesNCT04024774Centre Hospitalier Universitaire Dijon50